Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience our own tag's counts — open to see them
–Visits
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · visits, page views and clicks counted by our own tag, which counts more than our checked analytics; every figure rounded down · how we count

ReSOLVE review

#14 of 30 in AI Drug Discovery Software

Protein structure and dynamic water modeling guide screening and small-molecule optimization.

6.9/10Editor score
ReSOLVE6.9 Contact Ventus

Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026

ReSOLVE is Ventus Therapeutics’ proprietary drug-discovery platform for teams pursuing small-molecule medicines with protein structure as a guide. It combines AI and machine learning with protein science, structural biology, and biophysics. The workflow centers on modeling protein conformations—including rare configurations—and identifying druggable binding pockets, with dynamic water networks incorporated into the pocket model. Ventus says the platform powers its own therapeutic pipeline and can be used to screen targets beyond its scope through collaboration opportunities, making it a fit for enterprise discovery teams rather than a general-purpose research tool.

Its distinctive emphasis is the structural model behind screening. ReSOLVE creates hydrocophore blueprints to guide small-molecule identification and optimization, then virtually screens compound libraries, including libraries containing billions of compounds. Validated screening hits can inform subsequent screening and compound optimization, while high-resolution protein target structures support structure-based design. This ties target-focused pocket analysis to candidate finding and refinement; teams seeking drug repurposing or a broader suite spanning other discovery stages may need a different approach.

Commercial access is framed around collaboration, not a published self-serve plan: according to the vendor’s description, Ventus offers opportunities to screen targets outside its own scope. The published information does not specify commercial pricing or deployment arrangements, so prospective partners will need to discuss those directly with Ventus. ReSOLVE is most relevant when a team has a protein target and wants structure-informed virtual screening and optimization. It is less suited to buyers looking for a standalone subscription with transparent plan tiers or a platform centered on repurposing existing drugs.

ReSOLVE pros and cons

  • Where it wins
    • Models broad protein conformations, including rare configurations
    • Maps druggable pockets and dynamic water networks
    • Screens large compound libraries and supports hit-led optimization
  • Where it doesn't
    • Focused on molecule discovery rather than drug repurposing
    • Commercial access is through collaboration opportunities
    • Pricing and deployment details require direct vendor discussion

ReSOLVE fact sheet, pricing and score →

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.

Last updated · How we research and update